KEYNOTE

SPEAKERS

"The Next Frontier – Human-Centered Innovation in Psychosocial Oncology" 

Fred Ashbury, BA, MA, PhD FMASCC

  • 30+ Years of Cancer Leadership Experience
  • Chief Scientific Officer, VieCure (Colorado USA)
  • Former Senior Executive with Cancer Care Ontario
  • Former Senior Executive with the Alberta Cancer Board
  • Adjunct Professor, Division of Psychosocial Oncology, University of Calgary and Department of Internal Medicine, Medical Oncology, The Ohio State University
  • Editor-in-Chief, Supportive Care in Cancer; Editorial Boards of British Medical Journal Open and SN Clinical Comprehensive Medicine.
  • 175 peer-reviewed articles, abstracts and major reports in oncology, cancer care quality and supportive oncology
  • Member of the Canadian Association of Psychosocial Oncology (CAPO), including past Board Member and currently a member of CAPO’s Research Advisory Committee. He is also a member of the American Society of Clinical Oncology and International Psychosocial Oncology Society. Fred is currently a member of the Board (ex officio) for the Multi-National Association of Supportive Care in Cancer (MASCC) and Chair of the MASCC Guidelines Committee.
  • CAPO 2025 Lifetime Achievement Award
  • Inducted as a Fellow of the Multinational Association of Supportive Care in Cancer (June 2025).




                                         

Michelle Audoin

Michelle Audoin is an experienced and passionate patient advocate and community collaborator. She uses her living experience of cancer to shine a light on some of the disparities Black women experience when navigating a breast cancer diagnosis. Her advocacy work has also brought her to the research community where she contributes her knowledge and experiences to support clinical trials, cancer research, and collaborative intiatives including roles at CCTG as the Patient Representative Committee Chair, OICR PFAC, 3CTN, All.Can Canada, Princess Margaret and Women’s College Hospital, and as a planning committee member of the inaugural 2025 International Breast Cancer Survivorship and Supportive Care Conference held in Toronto.

After attending her first cancer conference several years ago, Michelle understood the importance of partnerships between both the research and patient advocate community, noting that knowledge empowers patients to not only understand cancer biology, but also to help set priorities regarding the future of cancer research, treatments and care. She also sees the impact these relationships have on healthcare providers who gain insights into the experiences of people living with or supporting someone with a cancer diagnosis and how to make their work more inclusive and accessible to diverse communities.

Michelle uses her background as an elementary school teacher to educate others by sharing her story and experiences on podcasts, panels, and awareness campaigns. She is most proud of raising two amazing and compassionate kids who support her cancer advocacy and patient engagement work.


"Is There a Place for Psychedelics in Psychosocial Oncology?"

Linda E. Carlson,PhD, R.Psych, FCAHS, FABMR (she/her) 

Session Description: 

Dr. Carlson will address the potential of psychedelic-assisted therapy for treating psychosocial symptoms such as demoralization and spiritual distress experienced by people with cancer. She will describe the work of the Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT), tasked with capacity building, determining research priorities, training researchers and clinicians, conducting clinical trials and influencing policy around psychedelics in cancer. 

Biography:

Dr. Linda Carlson holds the Enbridge Research Chair in Psychosocial Oncology and is a Full Professor in the Department of Oncology, Cumming School of Medicine at the University of Calgary. She directs the Alberta Complementary Therapy and Integrative Oncology (ACTION) Centre and has provided clinical care at Cancer Care Alberta since 1997.

A globally recognized leader in mindfulness-based cancer recovery and integrative oncology, Dr. Carlson has published over 250 peer-reviewed papers, co-authored influential books, and received numerous prestigious awards, including the 2023 Dr. Rogers Prize in Complementary and Alternative Medicine and the inaugural CAPO Research Excellence award in 2010. She also serves as Co-Editor-in-Chief of the Journal of Psychosocial Oncology Research and Practice (the official journal of IPOS)is Past-President of the Society for Integrative Oncology and Treasurer for the International Society for Contemplative Research.

INVITED

SYMPOSIUMS

"Navigating a road without a map: The psychosocial impacts of hereditary cancer syndromes"

Hereditary cancers account for up to 10% of the global cancer burden. In this invited symposia, we will explore the psychosocial impacts and challenges faced by individuals and families living with hereditary cancer risk. Designed for healthcare providers, researchers, and patients and families, the session will provide an overview of hereditary cancers — what they are, their prevalence, associated risks, and current approaches to risk management and counselling.

The symposia will feature a multidisciplinary panel including a genetic counsellor, a researcher, and a patient partner who will share lived and professional experiences. Topics will include:

  • Emotional and psychological impacts of living with inherited cancer risk
  • Decision-making around risk management, including prophylactic surgeries and family planning
  • Managing lifelong uncertainty and coping strategies

Participants will gain practical insights into integrating psychosocial considerations into clinical care and research. The session will conclude with an open Q&A to foster dialogue and collaboration.

Panelists: A genetic counsellor from the Provincial Medical Genetics Program

Dr. Holly Etchegary is an Associate Professor in the Faculty of Medicine, Memorial University. She has an active research program in hereditary cancers, genomics health services research and patient-oriented research, particularly in oncology. She can speak to a wide range of psychosocial impacts faced by patients with cancer predisposition syndromes, informed by her involvement in local and national research projects and her work with patient partners.


Vanessa Francis is a patient partner and registered nurse who has been working in the area of family practice and primary care for over two decades. She has lived experience of hereditary cancer and has often been a patient partner for research projects focused on cancer predisposition syndromes. Vanessa can attest to the challenges of managing inherited cancer risk both as a carrier of a pathogenic variant and as a health care provider. 

AI in Healthcare

Supportive oncology, including psychosocial care, can include clinical trials where participant recruitment, retention, and participation is paramount for success. Is there a role for AI in this process, what are the ethical considerations, and how will we keep the “human in the loop”? Dr. Bell will review the ethics of gaining participants’ informed consent to clinical trials and how AI may improve comprehension, values-concordant decision-making, and equity (e.g., teach-back support, tailoring to health literacy, and language) while potentially reducing undue influence. She will identify key ethical risks and mitigation strategies and illustrate a consent workflow that incorporates AI in real trial operations.

Dr. Bender will discuss how digital tools, including artificial intelligence (AI), can increase access to care, improve understanding of treatment options and management of side effects, and connect patients to supportive care services. Using three case scenarios Dr. Bender will discuss how to optimize virtual appointments, technology-enabled navigation, and remote symptom management to better meet the supportive care needs of patients with cancer and cancer survivors.

Panelists:

Dr. Jennifer A.H. Bell, MA, PhD, is a Senior Bioethicist, Bioethics Research Lead, and Clinician-Scientist at the University Health Network (UHN). She holds a research appointment at The Institute for Education Research at UHN, is an Assistant Professor, Affiliate Scientist, in the Department of Psychiatry, University of Toronto, and member of the Joint Centre for Bioethics at the University of Toronto. Dr. Bell recently completed a research and leadership fellowship in compassion and AI through AMS Healthcare. Her program of research addresses emergent ethical issues at the frontier of cancer care, including the responsible use of AI to enable compassionate care.

Dr. Jackie Bender is a Scientist and Co-Lead of Equity, Diversity and Inclusion in the Department of Supportive Care at the Princess Margaret Cancer Centre, University Health Network, and an Associate Professor in the Dalla Lana School of Public Health and the Institute for Health Policy, Management and Evaluation at the University of Toronto. Dr. Bender has an innovative program of research in digital health, cancer survivorship and implementation science. Her research focuses on designing, implementing, and evaluating digital health innovations that improve cancer care access, experience, and outcomes, and promote health equity. Dr. Bender is also the Co-Chair of Digital Health for the Multinational Association of Supportive Care in Cancer.

Dr. John-Jose Nunez is the Associate Medical Director of Supportive Care at BC Cancer and Assistant Professor in the Department of Psychiatry at the University of British Columbia. A dual-trained cancer psychiatrist and computer scientist, his research uses artificial intelligence to improve outcomes for patients facing both cancer and mental illness or other supportive care needs. His work, published in leading journals and featured internationally, ranges from predicting cancer survival to identifying patients in need of counseling or psychiatric care, bridging the gap between data science and supportive cancer care.

Moderated by: Fred Ashbury, BA, MA, PhD FMASCC

CONFERENCE DINNER & SHOW:

6:30 to 9 p.m., Spirit of NL Productions, Theatre Gower, 208 Gower Street, Newfoundland, A1C 1R2

  • Doors open - 6:30 p.m.
  • Meal service - 7 p.m.
  • Show start - 8 p.m.

Come join us for an award-winning dinner and show experience!

THE NEWFOUNDLAND ‘N’ LABRADOR SHOWCASE is an original 55-minute comedic showcase emceed by one of Spirit of Newfoundland’s irreverent performers and featuring our talented cast and the Spirit of Newfoundland Band. It’s a full immersion into the music and stories of Newfoundland that represent our unique culture. It’s a real Newfoundland time.

So, what’s a “time”, you ask! Well, a time is one of those experiences that leaves audiences saying things like, “The man next to me laughed so hard his teeth fell out!” Seriously. A time is an absolutely fabulous social and cultural experience. And it always features:

  • amazing food and lots of it – with an appetizer, main, and dessert – served up by our culinary team led by Chef Colleen O’Rielly
  • foot-stomping songs and music with, of course, a little bit of that traditional sound with an accordion or fiddle 
  • and that world famous Newfoundland sense of humor so often heard in our dialogue and stories

A three-course dinner followed by:

  • Newfoundland Screech Cake, the Spirit of Newfoundland’s Signature Dessert! Slices of moist and delicious bundt cake infused with Newfoundland Screech rum with hints of vanilla, soaked in a rum glaze. Served with a generous helping of Spirit of Newfoundland’s versatile Rum Sauce and fluffy cream.

Registration includes dinner and the show. Drinks are extra, and you will be billed separately for these.

Advanced registration is required.

Fee: $110

CAPO is a registered charity and does not charge tax.

REGISTER FOR THE DINNER


CONFERENCE

CHAIR


Dr. Sheila Garland

Psychology, Memorial University

Planning Committee Members

  • Annett Korner
  • Sydney Wasserman
  • Cheryl Heykoop
  • Elaine Holden
  • Fred Ashbury
  • Kimberley Thibodeau
  • Megan Easton
  • Paula Newhook
  • Sitara Sharma

Canadian Association of
Psychosocial Oncology (CAPO)

189 Queen Street East, Suite 1
Toronto, ON M5A 1S2
P. 416-968-0207
[email protected]

Facebook Logo    twitter x logo    linkedin logo    linkedin logo

Privacy Policy | CAPO By-laws
© 1993-2026 - CAPO/ACOP

Canadian Association of Psychosocial Oncology • Association Canadienne d'Oncologie Psychosociale
Website powered by Funnel Communications